Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis
Open Access
- 23 January 2015
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 100 (5), 696-702
- https://doi.org/10.3324/haematol.2014.115345
Abstract
We have analyzed 1448 patients with acquired aplastic anemia, grafted between 2005 and 2009, and compared outcome of identical sibling (n=940) vs unrelated donor (n=508) transplants. When compared to the latter, sibling transplants were less likely to be performed beyond 180 days from diagnosis (39%vs 85%), to have a cytomegalovirus negative donor /recipient status (15% vs 23%), to receive anti-thymocyte globulin in the conditioning (52% vs 61%), and received more frequently marrow as a stem cell source (60% vs 52%). Unrelated donor grafts had significantly more acute grade II-IV (25% vs 13%) and significantly more chronic graft versus host disease (26% vs 14%). In multivariate analysis the risk of death of unrelated donor grafts was higher, but not significantly, compared to a sibling donor (p=0.16). The strongest negative predictor of survival was the use of peripheral blood as a stem cell source (p180 days (p=0.0005), patient age >20 years (p=0.0005), no anti-thymocyte globulin in the conditioning (p=0.003); and donor/recipient cytomegalovirus serostatus, other than negative/negative ( p=0.04). In conclusion, in multivariate analysis, the outcome of unrelated donor transplants for acquired aplastic anemia, is currently not statistically inferior when compared to sibling transplants, although patients are at greater risk of acute and chronic graft versus host disease . The use of peripheral blood grafts remains the strongest negative predictor of survival.Keywords
This publication has 20 references indexed in Scilit:
- Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva‐Asia Blood and Marrow Transplantation GroupBritish Journal of Haematology, 2013
- Recent improvement in outcome of unrelated donor transplantation for aplastic anemiaBone Marrow Transplantation, 2007
- Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemiaBlood, 2007
- Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipientHaematologica, 2007
- Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimensBlood, 2007
- Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow TransplantationHaematologica, 2007
- Comparable Outcomes of Matched-Related and Alternative Donor Stem Cell Transplantation for Pediatric Severe Aplastic AnemiaTransplantation and Cellular Therapy, 2006
- Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working PartyBone Marrow Transplantation, 2005
- Re: Twenty-Year Follow-Up in Patients with Aplastic Anemia Given Marrow Grafts from HLA-Identical Siblings and Randomized to Receive Methotrexate/Cyclosporine or Methotrexate Alone for Prevention of Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2005
- Marrow transplants from unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiationTransplantation and Cellular Therapy, 2001